Your browser is no longer supported. Please, upgrade your browser.
Settings
XPH SPDR S&P Pharmaceuticals ETF daily Stock Chart
XPH [NYSE]
SPDR S&P Pharmaceuticals ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.22%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-7.21%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-1.55%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio11.75 Perf Half Y-3.59%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-13.13%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range36.58 - 47.82 Perf YTD3.73%
Dividend0.25 P/FCF- EPS past 5Y- ROI- 52W High-15.20% Beta-
Dividend %0.62% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low10.85% ATR0.52
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)35.18 Volatility1.07% 1.21%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.61 Prev Close40.94
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume82.43K Price40.55
Recom- SMA20-3.78% SMA50-4.73% SMA200-1.71% Volume132,934 Change-0.95%
Aug-11-17 08:42AM  Peregrine Pharmaceuticals laid off one-fifth of its workforce MarketWatch
Aug-07-17 12:10PM  Teva's stock keeps plunging on heavy volume after Morgan Stanley downgrade MarketWatch
09:45AM  Q2 Earnings Fail to Impress Pharma ETF Zacks
Aug-03-17 09:59AM  Three Large Cap Pharma Picks That Can Outperform This Year Barrons.com
07:55AM  Teva's stock plunges on heavy volume after profit miss and slashed outlook MarketWatch
Aug-01-17 07:41AM  Bristol-Myers Squibbs 2Q17 Earnings: Virology Products Market Realist
Jul-31-17 09:39AM  What Trump could do to make Obamacare implode MarketWatch
Jul-28-17 03:36PM  Eli Lillys Business Segments in 2Q17 Market Realist
Jul-26-17 04:35PM  Bristol-Myers Squibbs 2Q17 Estimates: Expect Growth! Market Realist
Jul-24-17 12:35PM  What Analysts Recommend for Eli Lilly ahead of 2Q17 Results Market Realist
Jul-14-17 09:09AM  Understanding Allergans Revenue Stream for 2017 Market Realist
Jul-11-17 10:47AM  This week could be make or break for the GOP health care bill MarketWatch
Jul-10-17 03:10PM  What Lies Ahead for Pharma ETFs in Second Half 2017 Zacks
07:21AM  Kala sets terms of IPO to raise up to $96 million MarketWatch
Jul-07-17 04:07PM  A Look at Pharmaceutical ETFs in 2Q17 Market Realist
Jul-06-17 07:45AM  Egalet's stock plunges toward record low after stock offering plan MarketWatch
Jul-04-17 09:06AM  Performance of Mercks Gardasil and Other Human Vaccines in 1Q17 Market Realist
Jun-29-17 08:28AM  Why did these generic drugs prices jump as much as 85%? MarketWatch
Jun-21-17 01:03PM  Drug stocks surge on report that President Trump plans to ease industry regulations MarketWatch
Jun-20-17 07:36AM  Key Updates on Eli Lillys Jardiance Market Realist
Jun-19-17 07:45AM  Valeant's stock surges after largest shareholder John Paulson elected to board MarketWatch
Jun-08-17 10:36AM  Why Pfizers Products Lost Market Share in 1Q17 Market Realist
Jun-02-17 07:37AM  Performance of Eli Lillys New Products Portfolio in 1Q17 Market Realist
May-30-17 03:35PM  Changes in Johnson & Johnsons Revenue in 1Q17 Market Realist
May-25-17 07:35AM  Mercks Immunology and Cardiovascular Franchise in 1Q17 Market Realist
May-19-17 07:36AM  What Happened to Bristol-Myers Squibbs Opdivo in 1Q17? Market Realist
May-10-17 06:05PM  Behind Allergans US Specialized Therapeutics Segment in 1Q17 Market Realist
May-09-17 07:14AM  Valeant's stock soars after profit beats expectations MarketWatch
May-08-17 05:42PM  ETF Flopper: Biotechnology and Pharmaceuticals Feel the Pain Barrons.com
09:01AM  Mallinckrodt's stock jumps after profit and sales beat MarketWatch
May-02-17 07:37AM  Eli Lillys 1Q17 Earnings: Cialis and Other Cardiovascular Products Market Realist
Apr-28-17 03:35PM  Eli Lillys Business Segments and Their Performance in 1Q17 Market Realist
Apr-26-17 07:37AM  A Look at Bristol-Myers Squibbs Oncology Segment in 1Q17 Market Realist
Apr-21-17 09:06AM  Johnson & Johnsons Consumer Segments 1Q17 Earnings Market Realist
Apr-20-17 11:31AM  Analyst Estimates for Eli Lillys 1Q17 Earnings Market Realist
Apr-14-17 10:36AM  Analysts Ratings for Johnson & Johnson in 1Q17 Market Realist
Apr-11-17 11:29AM  The Hybrid US Healthcare System: An Overview Market Realist
Apr-10-17 07:36AM  How Pfizer Stock Performed in 1Q17 Market Realist
Apr-07-17 06:59PM  ETF Flyers: Pharmaceuticals Barrons.com
Mar-31-17 07:36AM  Analyzing LLYs Cardiovascular Franchises 2016 Performance Market Realist
07:36AM  Analyzing LLYs Cardiovascular Franchises 2016 Performance
Mar-29-17 09:30AM  The Zacks Analyst Blog Highlights: HCA Holdings, Molina Healthcare, SPDR S&P Pharmaceuticals ETF, BioShares Biotechnology Products Fund and The Health Care Select Sector SPDR Fund Zacks
09:30AM  The Zacks Analyst Blog Highlights: HCA Holdings, Molina Healthcare, SPDR S&P Pharmaceuticals ETF, BioShares Biotechnology Products Fund and The Health Care Select Sector SPDR Fund at Investopedia
Mar-27-17 06:04PM  ETF Flyer: Healthcare Stocks Continue To Dance On the Grave Of The Failed GOP Bill Barrons.com
06:04PM  ETF Flyer: Healthcare Stocks Continue To Dance On the Grave Of The Failed GOP Bill at Barrons.com
Mar-20-17 10:22AM  Trump, Biogen and Amgen Hammer Healthcare ETFs Zacks
Mar-16-17 03:05PM  Analyzing Bristol-Myers Squibbs 2016 Performance Market Realist
03:05PM  Analyzing Bristol-Myers Squibbs 2016 Performance
Mar-15-17 04:33PM  Should You Buy Pharma ETFs Now? Zacks
09:05AM  Johnson & Johnsons Financial Guidance for 2017 Market Realist
09:05AM  Johnson & Johnsons Financial Guidance for 2017
Mar-14-17 04:03PM  Aurinias stock plunges after big share offering at deep discount MarketWatch
04:03PM  Aurinias stock plunges after big share offering at deep discount at MarketWatch
Mar-08-17 10:07AM  Trump Tweet on Drug Pricing Hits Biotech and Pharma ETFs Zacks
Mar-07-17 04:05PM  Stocks Fall for Day Two as Trump Targets Health Care Sector
02:24PM  Stock market loses ground as energy shares weigh at MarketWatch
09:16AM  Pharma and biotech stocks slump after President Trump tweets about lowering drug prices at MarketWatch
Mar-06-17 10:36AM  How Mylan Is Valued after 4Q16 Earnings
Mar-01-17 04:14PM  Best & Worst ETFs of February 2017
01:24PM  Investors have stopped believing Trumps drug price threats at MarketWatch
08:23AM  Bernie Sanders has some new allies in fight to bring Canadian drugs to the U.S. at MarketWatch
Feb-27-17 08:22AM  Pieris Pharmaceuticals' stock soars after exclusive license deal with Japan's ASKA at MarketWatch
07:32AM  La Jolla Pharmaceutical's stock rockets in active trade after positive trial results at MarketWatch
Feb-24-17 10:38AM  Eli Lilly & Co.s Cardiovascular Franchise
Feb-23-17 07:47AM  Gardasil Driving Merck & Co.s Vaccines Business in 4Q16
Feb-07-17 04:42PM  Drug stocks dip after Spicer affirms Trumps stance on cutting costs at MarketWatch
Feb-06-17 09:55AM  Q4 Earnings Faring Well for Pharma ETFs
Jan-26-17 09:06AM  What to Expect from Eli Lillys Cardiovascular Franchise in 4Q16
Jan-20-17 09:59AM  A.M. Funds Roundup: Investors Buy Volatility ETFs, Exit Equity ETFs Ahead Of Inauguration, at Barrons.com
Jan-19-17 04:06PM  What Lies Ahead for Pharma ETFs?
Jan-17-17 11:16AM  Biotech ETFs: When Will The Pain End? at Barrons.com
Jan-12-17 12:01PM  Biotech ETFs Continue To Bleed at Barrons.com
12:00PM  Trump's First Press Conference Puts These ETFs in Focus
10:37AM  Mylans Specialty Segment: The Effect of Falling EpiPen Sales
Jan-11-17 04:30PM  The Biggest Loser: Endo International Tumbles 8.6% at Barrons.com
01:03PM  2 Stocks For a Trump-ed Up Pharma Market at Barrons.com
12:09PM  Biotech, Pharma ETFs Sink; Trump Promises "Bidding Procedures" at Barrons.com
Dec-20-16 08:19AM  Tesaro NDA for ovarian cancer treatment granted priority review at MarketWatch
07:36AM  It Was a Successful 3Q16 for Horizon Pharmas Primary Care
Dec-16-16 08:37AM  Mylan's first generic EpiPen launches at less than half the cost of branded version at MarketWatch
Dec-14-16 08:05AM  Loss of Patent Protection to Drag Pfizers Top Line
Dec-12-16 09:36AM  Ibrance Is the Only Registered CDK 4/6 Inhibitor for Breast Cancer
Dec-09-16 07:26AM  Express Scripts stock rocked by tweets from short seller Andrew Left at MarketWatch
Dec-08-16 03:00PM  Biotech & Pharma ETFs to Suffer in 2017 Too?
01:43PM  Express Scripts' stock dives after short seller Andrew Left takes aim at MarketWatch
Dec-07-16 02:11PM  President-elect Trumps promise to bring down drug prices sends biotech and pharma ETFs slumping at MarketWatch
12:40PM  Trumps Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares at 24/7 Wall St.
11:31AM  Biotech ETFs: So Much For The Trump Bounce at Barrons.com
Dec-05-16 11:05AM  Inside Mercks Profitability after 3Q16
Dec-02-16 04:05PM  Two Nano-Cap Pharma Stocks To Watch Right Now at Insider Monkey
10:49AM  5 Secret Santa ETFs & Stocks for Your Portfolio
Dec-01-16 08:51AM  Five ways to evaluate an Obamacare replacement plan at MarketWatch
08:50AM  What to expect from HHS Secretary nominee and Obamacare opponent Tom Price at MarketWatch
Nov-30-16 06:21PM  A Closer Look at Mercks Valuation Compared to Peers
Nov-27-16 04:54PM  Where Else Have We Seen Mallinckrodts Acquire to Invest Strategy?
Nov-23-16 10:04AM  What You Need to Know about Eli Lillys Cardiovascular Franchise
Nov-22-16 11:04AM  What Do the Analysts Recommend for Bristol-Myers Squibbs Stock?
Nov-17-16 12:18PM  Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios
Nov-16-16 08:15AM  Biotech takes Trump presidency as a green light and end to drug price worries at MarketWatch
Nov-14-16 10:57AM  5 Reasons to Buy 5 Low P/E Biotech ETFs
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.